cytidine has been researched along with balapiravir in 7 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 4 (57.14) | 29.6817 |
| 2010's | 3 (42.86) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Berns, H; Cooksley, G; Dore, GJ; Hill, G; Klumpp, K; Najera, I; Roberts, SK; Robson, R; Shaw, D; Washington, C | 1 |
| Chan, A; Everson, GT; Fried, MW; Ghalib, R; Godofsky, E; Harrison, S; Hill, G; Najera, I; Nelson, D; Nyberg, L; Pockros, PJ; Rodriguez-Torres, M; Shiffman, ML | 1 |
| Alfredson, T; Birudaraj, R; Brandl, M; Hadig, X; Hill, G; Holper, M; Hong, L; Jia, Z; Larrabee, S; Reddy, M; Sarma, K; Smith, DB; Tran, T; Washington, C; Wu, X | 1 |
| Kronenberger, B; Zeuzem, S | 1 |
| Alfredson, T; Brandl, M; Hadig, X; Hong, L; Huang, S; Li, F; Tran, T; Wu, X | 1 |
| Abdul Ghafar, N; Blasco, F; Cerny, D; Chen, YL; Fink, K; Fu, Y; Gu, F; Herve, M; Karuna, R; Lim, SP; Schul, W; Shi, PY; Wang, G; Yokohama, F | 1 |
| Behera, I; Beigelman, L; Chaudhuri, S; Deval, J; Dyatkina, N; Jekle, A; Jin, Z; Kinkade, A; Rajwanshi, VK; Smith, DB; Symons, JA; Tucker, K; Wang, G | 1 |
1 review(s) available for cytidine and balapiravir
| Article | Year |
|---|---|
Future treatment options for HCV: double, triple, what is the optimal combination?
Topics: Antiviral Agents; Cytidine; DNA-Directed RNA Polymerases; Drug Delivery Systems; Drug Resistance, Viral; Drug Therapy, Combination; Forecasting; Hepatitis C, Chronic; Humans; Interferon alpha-2; Interferon-alpha; Nucleosides; Oligopeptides; Polyethylene Glycols; Prodrugs; Proline; Protease Inhibitors; Pyrimidine Nucleosides; Recombinant Proteins; Ribavirin | 2008 |
2 trial(s) available for cytidine and balapiravir
| Article | Year |
|---|---|
Robust antiviral activity of R1626, a novel nucleoside analog: a randomized, placebo-controlled study in patients with chronic hepatitis C.
Topics: Adult; Alanine Transaminase; Antiviral Agents; Cytidine; Dose-Response Relationship, Drug; Drug Resistance, Viral; Female; Hepacivirus; Hepatitis C, Chronic; Humans; Male; Middle Aged; Nucleosides; Prodrugs; RNA, Viral; Single-Blind Method; Time Factors; Viral Load | 2008 |
R1626 plus peginterferon Alfa-2a provides potent suppression of hepatitis C virus RNA and significant antiviral synergy in combination with ribavirin.
Topics: Adult; Aged; Aged, 80 and over; Alanine Transaminase; Antiviral Agents; Cytidine; Dose-Response Relationship, Drug; Double-Blind Method; Drug Resistance, Viral; Drug Synergism; Drug Therapy, Combination; Female; Hepacivirus; Humans; Interferon alpha-2; Interferon-alpha; Male; Middle Aged; Neutropenia; Nucleosides; Polyethylene Glycols; Prodrugs; Recombinant Proteins; Ribavirin; RNA, Viral; Treatment Outcome; Viral Load | 2008 |
4 other study(ies) available for cytidine and balapiravir
| Article | Year |
|---|---|
Physicochemical properties of the nucleoside prodrug R1626 leading to high oral bioavailability.
Topics: Antiviral Agents; Biological Availability; Caco-2 Cells; Cytidine; DNA-Directed RNA Polymerases; Dose-Response Relationship, Drug; Drug Stability; Hepacivirus; Humans; Hydrolysis; Nucleosides; Particle Size; Permeability; Prodrugs; Solubility; Viral Nonstructural Proteins | 2008 |
Chemical stability of 4'-azidocytidine and its prodrug balapiravir.
Topics: Antiviral Agents; Azides; Chemical Phenomena; Cytidine; Drug Stability; Hydrogen-Ion Concentration; Nucleosides; Prodrugs | 2010 |
Activation of peripheral blood mononuclear cells by dengue virus infection depotentiates balapiravir.
Topics: Animals; Antiviral Agents; Cytidine; Cytokines; Dengue; Dengue Virus; Female; Humans; Leukocytes, Mononuclear; Mice; Nucleosides; Prodrugs | 2014 |
Structure-activity relationship analysis of mitochondrial toxicity caused by antiviral ribonucleoside analogs.
Topics: Adenosine; Amides; Antiviral Agents; Cell Line; Cytidine; DNA-Directed RNA Polymerases; Guanosine Monophosphate; Humans; Inhibitory Concentration 50; Mitochondria; Mitochondrial Proteins; Nucleosides; Prodrugs; Protein Biosynthesis; Pyrazines; Ribonucleosides; RNA; RNA, Mitochondrial; Sofosbuvir; Structure-Activity Relationship; Transcription Initiation Site; Transcription, Genetic | 2017 |